Home » CORGENIX SUBMITS FDA PREMARKET NOTIFICATION OF ASPIRINWORKS TEST KIT
CORGENIX SUBMITS FDA PREMARKET NOTIFICATION OF ASPIRINWORKS TEST KIT
Corgenix Medical Corporation, a worldwide developer and marketer of diagnostic test kits, has submitted a Premarket Notification (510k) to the U.S. Food and Drug Administration (FDA) for the Company's AspirinWorks Test Kit, the Company's newest diagnostic product for cardiovascular disease.
Business Wire
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May